Related Experiment Videos
Managing hereditary ovarian cancer risk
A Berchuck1, J M Schildkraut, J R Marks
1Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Cancer
|January 12, 2000
Summary
Prophylactic oophorectomy for hereditary ovarian cancer may offer less benefit than expected. Further research is needed to clarify risks and benefits for BRCA1/BRCA2 mutation carriers.
Area of Science:
- Gynecologic Oncology
- Cancer Genetics
- Preventive Medicine
Background:
- Ovarian cancer is a leading cause of cancer death in women.
- Hereditary factors, particularly BRCA1 and BRCA2 mutations, account for approximately 10% of cases.
- Family history is the most significant known risk factor for ovarian cancer.
Purpose of the Study:
- To evaluate the proven benefits of prophylactic oophorectomy in women with hereditary ovarian cancer.
- To address the uncertainty surrounding the efficacy of oophorectomy in BRCA1/BRCA2 mutation carriers.
- To explore alternative strategies for reducing ovarian cancer mortality in high-risk individuals.
Main Methods:
- Review of existing literature on prophylactic oophorectomy efficacy.
- Analysis of reported ovarian cancer risks in BRCA1/BRCA2 mutation carriers.
- Assessment of post-oophorectomy risks, including peritoneal papillary serous carcinoma.
Main Results:
- Lifetime ovarian cancer risk in mutation carriers may be lower than previously estimated (15-30% vs. 60%).
- The protective effect of prophylactic oophorectomy requires further definition.
- Peritoneal papillary serous carcinoma can occur after oophorectomy, complicating risk-benefit analysis.
Conclusions:
- The precise benefit of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers remains uncertain.
- Understanding factors influencing variable penetrance is crucial for genetic counseling.
- Chemoprevention and early detection strategies warrant consideration for high-risk women.